Skip to main content
. 2019 Mar 27;25(9):1497–1509. doi: 10.1093/ibd/izz049

FIGURE 2.

FIGURE 2.

Baseline percentages of CD103+, CD103+CD4+, CD103+CD8+, CD103-CD4+, and CD103-CD8+ within CD3+ T-lymphocytes and the ratio CD4+/CD8+ T-lymphocytes explored with FACS analysis on ileal biopsies of CD patients with active ileal disease compared with healthy controls. *Significant P value.